Skip to content
Advertisement

Tom Howell Jr.

Tom Howell Jr.

Tom Howell Jr. covers politics and the White House for The Washington Times. He can be reached at thowell@washingtontimes.com.

Articles by Tom Howell Jr.

Medical Assistant Keona Shepard holds up the Johnson & Johnson COVID-19 vaccine as she prepares to administer it at the New Orleans Ernest N. Morial Convention Center during the mass coronavirus vaccination on Thursday, March 4, 2021 in New Orleans. (Chris Granger /The Advocate via AP)

Governors hype new Johnson & Johnson vaccine in public events

The Johnson & Johnson vaccine is being received with enthusiasm across the country but Detroit Mayor Mike Duggan allowed his share of 6,000 doses to go elsewhere this week, saying he can meet the needs of those eligible with alternative vaccines he views as better. Published March 5, 2021

Texas Gov. Greg Abbott speaks about the winter storm during a press conference at the State Operations Center, Thursday Feb. 18, 2021, in Austin, Texas. ( Jay Janner/Austin American-Statesman via AP)

Greg Abbott rescinds mask mandate in Texas, opens business

Texas Gov. Greg Abbott said Tuesday he is ending a statewide mask mandate and will allow businesses to reopen at full capacity even as the virus circulates at dangerous levels, saying residents are suffering economically and vaccines provide a way out of the pandemic. Published March 2, 2021

President Joe Biden speaks about efforts to combat COVID-19, in the State Dining Room of the White House, Tuesday, March 2, 2021, in Washington. (AP Photo/Evan Vucci)

Merck to help J&J make its vaccine

President Biden said Tuesday that he expects the U.S. to have enough vaccines for every adult by the end of May, instead of July, as pharmaceutical giant Merck agreed to help rival Johnson & Johnson make its COVID-19 vaccine. Published March 2, 2021

In this file photo, former president Donald Trump speaks at the Conservative Political Action Conference (CPAC) Sunday, Feb. 28, 2021, in Orlando, Fla. (AP Photo/John Raoux)  **FILE**

Trump, first lady Melania Trump got COVID-19 vaccine in January

President Trump and first lady Melania Trump were vaccinated against COVID-19 at the White House in January -- something that wasn't publicly known at the time, as other top officials rolled up their sleeves for the camera to ensure continuity of government and bolster confidence in the shots. Published March 1, 2021

FILE - This September 2020, file photo provided by Johnson & Johnson shows a pharmacist preparing to give an experimental COVID-19 vaccine. The U.S. is getting a third vaccine to prevent COVID-19, as the Food and Drug Administration on Saturday, Feb. 27, 2021 cleared a Johnson & Johnson shot that works with just one dose instead of two. (Johnson & Johnson via AP, File)

FDA approves J&J vaccine for emergency use

The Food and Drug Administration on Saturday approved the one-dose Johnson & Johnson vaccine for emergency use, clearing the way for up to 4 million doses to ship within days as demand outstrips the supply of two existing vaccines. Published February 27, 2021

Navy personnel prepare for the opening of a mass COVID-19 vaccination site in the Queens borough of New York, Wednesday, Feb. 24, 2021. This FEMA-run site, along with another in Brooklyn, gives priority to local residents in an effort to equitably distribute the vaccine. (AP Photo/Seth Wenig, Pool) **FILE**

CDC director sounds alarm over ‘plateau’ in COVID-19 cases

The Biden administration sounded the alarm Friday over a "very concerning shift" in the coronavirus pandemic in recent days, as case counts plateau instead of fall and estimates show the "U.K." variant accounts for 10% of reported U.S. infections. Published February 26, 2021

This Dec. 2, 2020, file photo provided by Johnson & Johnson shows vials of the Janssen COVID-19 vaccine in the United States. (Johnson & Johnson via AP)

FDA: J&J one-shot COVID-19 vaccine meets standards

The Food and Drug Administration endorsed a single-shot vaccine from Johnson & Johnson for emergency use in a staff report issued Wednesday, putting the U.S. on track to having a third weapon in the COVID-19 fight by next week. Published February 24, 2021